48
Participants
Start Date
September 17, 2020
Primary Completion Date
April 25, 2024
Study Completion Date
April 25, 2024
Abaloparatide 80 micrograms per Pen dose
prefilled injector pen to deliver 80 micrograms daily subcutaneously
Placebo prefilled injector pen
prefilled injector pen to deliver inactive solution daily subcutaneously
Hospital for Special Surgery, New York
Mount Sinai, New York
Westchester Medical Center, Valhalla
Weill Medical College of Cornell University
OTHER
Icahn School of Medicine at Mount Sinai
OTHER
New York University
OTHER
Westchester Medical Center
OTHER
Hospital for Special Surgery, New York
OTHER